These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3208689)

  • 1. [Plasminogen activators in malignant tissues and lungs of mice during metastatic spreading and administration of various pharmacological agents].
    Chubinskaia SG; Makogonenko EM; Veksler IG
    Eksp Onkol; 1988; 10(5):46-9. PubMed ID: 3208689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemical changes in the connective tissue components of malignant tumors and lungs in mice during metastatic spreading and chemotherapy].
    Chubinskaia SG; Sevast'ianova NA; Veksler IG; Slutskiĭ LI
    Vopr Med Khim; 1989; 35(5):30-4. PubMed ID: 2617932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the metastatic spread of transplanted tumors under high-altitude conditions].
    Kulish OP
    Eksp Onkol; 1987; 9(5):73-5. PubMed ID: 3691398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elastase activity during growth and metastasis of tumors andthe pharmacological effects in C57Bl/6 mice].
    Chubinskaia SG
    Eksp Onkol; 1990; 12(1):53-6. PubMed ID: 2298144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of plasminogen activator of the head and neck tumor tissue].
    Ji X; Nong H; Huang G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of cyclic nucleotides in the development of resistance to metastases after treatment with immunomodulators].
    Veksler IG; Antonenko SG; Okolot EN; Chubinskaia SG
    Eksp Onkol; 1984; 6(3):52-5. PubMed ID: 6094145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals.
    Shapiro RL; Duquette JG; Roses DF; Nunes I; Harris MN; Kamino H; Wilson EL; Rifkin DB
    Cancer Res; 1996 Aug; 56(15):3597-604. PubMed ID: 8758932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of unithiol on the antineoplastic and antimetastatic activity of N-methylformamide].
    Proskuriakov SIa; Fedorovskaia EO; Riabchenko NI; Poverennyĭ AM
    Vopr Med Khim; 1993; 39(3):32-4. PubMed ID: 8333188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator activity of metastatic variants from a murine fibrosarcoma; effect of thrombin in vitro.
    Coen D; Bottazzi B; Bini A; Conforti MG; Mantovani A; Mussoni L; Donati MB
    Int J Cancer; 1983 Jul; 32(1):67-70. PubMed ID: 6683249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature.
    Muzykantov VR; Barnathan ES; Atochina EN; Kuo A; Danilov SM; Fisher AB
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1026-34. PubMed ID: 8930213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes].
    Veksler IG; Riabukha VN; Smelkova MI; Balitskiĭ KP
    Eksp Onkol; 1984; 6(6):50-3. PubMed ID: 6441701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the total proteolytic activity and inhibitory potential of tumor and lung tissue in mice during growth and metastatic spread of malignant neoplasms].
    Veksler IG; Veremeenko KN; Riabukha VN; Pogorelaia NF; Khaniuchenko SI
    Eksp Onkol; 1987; 9(5):68-70. PubMed ID: 3319519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
    Colombi M; Bellotti D; De Petro G; Barlati S
    Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.
    Markus G; Camiolo SM; Kohga S; Madeja JM; Mittelman A
    Cancer Res; 1983 Nov; 43(11):5517-25. PubMed ID: 6193874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of zinc status on the anti-Lewis lung tumour activity of cisplatin and gallium.
    Capel ID; Dorrell HM; Pinnock MH; Jenner M; Williams DC
    Anticancer Res; 1981; 1(5):269-73. PubMed ID: 7201776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental model for quantitative study of metastasis.
    Ossowski L; Reich E
    Cancer Res; 1980 Jul; 40(7):2300-9. PubMed ID: 7190062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.
    Shah V; Kumar S; Zirvi KA
    In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.